K

KBI Biopharma

CDMO delivering cell line development

In-Process Support Associate

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeDurham, NC, USAIn-person

About the Job

Requirements

  • A Bachelor of Science in a scientific discipline or equivalent is required.
  • Experience in quality control analysis of proteins, antibodies, peptides, or vaccines is preferred but not required.
  • Experience working in a current Good Manufacturing Practice (cGMP) environment is preferred.
  • Strong verbal and written communication skills are required.

Responsibilities

  • Perform testing on in-process materials or drug substance and drug product using bio-analytical techniques such as high-performance liquid chromatography, ultraviolet-visible spectroscopy, and simple compendial testing; exercise technical discretion in executing and interpreting experiments that contribute to project goals.
  • Make detailed observations and perform elementary data analysis.
  • Understand experiments, conduct troubleshooting analysis, and maintain knowledge of instrumentation.
  • Maintain and write documentation, including notebooks and worksheets.
  • Maintain familiarity with current scientific literature and professional expertise.
  • Ensure proper labeling, handling, and storage of chemicals; properly label and dispose of hazardous waste in the satellite area; follow safety requirements and procedures; and attend required safety and health training, including hazardous-waste handling.
  • Respond productively to change and perform other essential tasks as assigned.
  • Primarily work first-shift hours, with occasional night, weekend, or holiday work; provide off-shift coverage on a rotating as-needed basis.

Desired Qualifications

  • Experience in quality control analysis of proteins, antibodies, peptides, or vaccines.
  • Experience working in a current Good Manufacturing Practice (cGMP) environment.

About the Company

KBI Biopharma

CDMO delivering cell line development

KBI Biopharma is a CDMO that accelerates the development of biological medicines by providing rapid cell line generation and process development for preclinical programs. It uses established mammalian and microbial expression systems (such as CHO K1, CHO S, CHO DG44, HEK293, and DXB11 E. coli) to create production cell lines and develop integrated manufacturing processes. Compared with competitors, it wins on speed, end-to-end capability, and flexibility across multiple platforms to move projects quickly from discovery to preclinical milestones for a diverse client base. Its goal is to reduce risk, shorten development timelines, and expand global access to life-saving biologic therapies.

Company size
1,001-5,000
Company stage
Late Stage VC
Total funding
$109.5M
Headquarters
Durham, NC
Founded
1996

Recently Posted Jobs

Explore more opportunities at KBI Biopharma

See more jobs